DLB — Dolby Laboratories Cashflow Statement
0.000.00%
- $7.30bn
- $6.79bn
- $1.27bn
- 96
- 34
- 87
- 85
Annual cashflow statement for Dolby Laboratories, fiscal year end - September 27th, USD millions except per share, conversion factor applied.
2020 September 25th | 2021 September 24th | 2022 September 30th | 2023 September 29th | 2024 September 27th | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 53 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 232 | 318 | 184 | 202 | 264 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 108 | 95.8 | 132 | 143 | 116 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -81.1 | -24.6 | -56.3 | -42 | -107 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 344 | 448 | 319 | 367 | 327 |
Capital Expenditures | -69 | -54.5 | -59.5 | -30.3 | -30 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 203 | 9.55 | -236 | 84.5 | -256 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | 134 | -44.9 | -296 | 54.2 | -286 |
Financing Cash Flow Items | -5.04 | -7.36 | -1.44 | -0.766 | -15.1 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | -208 | -253 | -611 | -237 | -288 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 274 | 153 | -605 | 190 | -240 |